当前位置:首页 > 股票大全 > 昆药集团 600422 财务分析

昆药集团财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

昆药集团(600422)利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入7,703,121,256.835,610,863,771.763,770,638,315.781,910,049,890.78
营业总成本7,153,005,232.635,165,454,500.493,497,605,652.321,744,130,961.09
营业利润568,495,884.08476,440,196.39282,119,044.98169,611,704.12
利润总额563,619,899.14476,776,592.65283,431,191.53168,324,573.09
净利润454,142,715.55396,225,301.95230,527,045.06134,211,509.35
其他综合收益-7,802,549.3-1,085,751.36600,365.65-266,168.04
综合收益总额446,340,166.25395,139,550.59231,127,410.71133,945,341.31
昆药集团(600422)资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计7,031,044,519.896,698,253,583.066,407,462,369.516,572,032,498.51
非流动资产合计2,534,338,753.282,592,276,021.832,618,266,710.092,672,402,054.96
资产总计9,565,383,273.179,290,529,604.899,025,729,079.69,244,434,553.47
流动负债合计3,644,258,827.363,451,363,584.623,423,951,214.133,569,616,633.56
非流动负债合计444,555,046.85429,898,477.01356,352,670.7405,451,038.16
负债合计4,088,813,874.213,881,262,061.633,780,303,884.833,975,067,671.72
归属于母公司股东权益合计5,297,444,082.365,246,812,921.765,086,031,076.885,113,945,754.17
股东权益合计5,476,569,398.965,409,267,543.265,245,425,194.775,269,366,881.75
负债和股东权益合计9,565,383,273.179,290,529,604.899,025,729,079.69,244,434,553.47
昆药集团(600422)现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计8,195,155,991.135,638,387,159.13,657,859,303.511,453,896,838.72
经营活动现金流出小计7,839,072,830.835,674,759,077.383,947,052,960.662,010,786,008.18
经营活动产生的现金流量净额356,083,160.3-36,371,918.28-289,193,657.15-556,889,169.46
投资活动现金流入小计1,713,262,187.71760,069,554.65597,474,245.21586,444,278.41
投资活动现金流出小计2,052,481,995.38977,260,160.72375,996,593.66283,148,621.62
投资活动产生的现金流量净额-339,219,807.67-217,190,606.07221,477,651.55303,295,656.79
筹资活动现金流入小计989,035,197.24811,899,868.25378,578,070135,477,921.62
筹资活动现金流出小计1,190,876,222.491,053,223,234.07693,533,578.41251,924,832.29
筹资活动产生的现金流量净额-201,841,025.25-241,323,365.82-314,955,508.41-116,446,910.67
汇率变动对现金及现金等价物的影响1,728,205.161,805,750.931,897,142.53-757,126.15
现金及现金等价物净增加额-183,249,467.46-493,080,139.24-380,774,371.48-370,797,549.49
期末现金及现金等价物余额1,365,937,403.371,056,106,731.591,168,412,499.351,178,389,321.33
昆药集团600422相关数据
今日股市大盘指数